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area. Different analysis techniques have been proposed to increase 
the accuracy of radiochromic films dose distribution measurements.  
The aim of this work is to compare the results obtained whit different 
analysis techniques in assessing dose distribution for IMRT photon 
beams pre-treatment verification.  
Materials and Methods: Gafchromic®EBT3 films have been calibrated 
irradiating 5x5 cm film pieces with a 6 MV linac photon beam at 
different dose levels in a range from 10 to 400 cGy at 5cm depth in 
PMMA phantom and SSD 95 cm. Then 40 IMRT clinical beams have been 
verified by gafchromic films with the same irradiation setup. Films 
have been scanned with a Epson 10000XL flatbed scanner 24 hours 
after irradiation and dose distributions have been assessed using an 
home-made software. Our software allows to perform analysis in 4 
different ways: red channel (R) analysis, red channel analysis with the 
correction for the scanner non-uniformities (RC), the red/blue 
channels (RB) analysis and the 3 channel (RGB) analysis using formulas 
proposed by Mayer (Med. Phys. 2012). The films absolute dose 
distributions obtained have been compared with the calculated ones 
by means of 3%(local)/3mm gamma analysis.  
Results: Gamma analysis pass rates obtained with RGB analysis 
(98.0±2.7) are higher than pass rates obtained with all the other 
analysis approaches, while the lowest mean pass rate (88.9±13.3) has 
been obtained, as is was expected, evaluating the dose distribution 
using the R analysis. Comparing RB and RC techniques, the last one 
provide better results (96.5 ± 3.4 vs 94.1 ± 7.2). Moreover standard 
deviations of mean values are inversely proportional to gamma pass 
rates meaning that methods giving higher pass rates are also more 
consistent. 
Conclusions: The newly proposed three channels analysis allows to 
take in account different source of inaccuracy increasing the 
gafchromic films capability to measure IMRT dose distributions.  
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Purpose/Objective: Verification of the position of MLC leaves is an 
essential part of routine linac quality assurance. This is particularly 
true when more advanced treatment techniques such as 
VMAT/RapidArc and IMRT are used. These treatments are typically 
built up out of smaller, possibly abutting fields, amplifying the effect 
of any mispositioning of the leaves. The Elekta Agility MLC (Elekta, 
Crawley, UK) has 160 leaves, with 0.5 cm effective leaf width in the 
isocentre. It comes with an automated tool to calibrate the leaf 
position offsets and motion gains. This is a 'black-box', and direct 
control over leaf positioning is no longer possible, but independent 
verification is still essential. The aim of the research presented was 
twofold: 1. To test the MLCSoftEPID software (PTW, Freiburg, 
Germany) as a quick tool for routine MLC QA, as an alternative to 
detector arrays or film. 2. To test the positioning stability of the 
Elekta Agility MLC. 
Materials and Methods: An Elekta Synergy linac fitted with an Agility 
MLC was used. The EPID used was an IviewGT amorphous silicon 
1024x1024 pixel EPID, with a 41x41 cm detection area (Perkin-Elmer, 
Waltham Massachusetts, US). MLCSoftEPID software was used for 
analysis. This software package requires a standard set of EPID images 
to be acquired for accurate alignment of the coordinate system of the 
EPID panel in relation to the linac collimator, followed by a series of 
strip images from which the leaf positions are then determined, 
analogous to a picket-fence test. Measurements were compared to our 
institute's standard SLA-48 (PTW, Freiburg, Germany), a linear array of 
ionization chambers mounted on a stepper motor. To test whether the 
measurement of a leaf's position is influenced by the position of 
neighbouring leaves, images were also made with all odd-numbered 
leaves intentionally offset by 2 mm compared to even-numbered 
leaves. In this case, the 50% dose level is no longer directly beneath 
what would normally be considered the leaf position, due to the 
nonzero size of the point spread function (see figure). Positioning 
accuracy for each leaf was tracked biweekly over a period of multiple 
months. 
  
Results: A routine leaf position QA check using MLCSoftEPID can be 
done within 10 minutes. Consecutive leaf position measurements using 
the EPID were found to be reproducible within 0.1mm every time, 
comparable to or better than traditional alternatives, and agree with 
conventional SLA-48 measurements within 0.3 mm. Over the 3 months 
during which leaf stability was measured, all individual leaf positions 
of the Agility deviated by less than 0.2mm. A non-negligible effect 
caused by a mispositioning of neighbouring leaves on the position of a 
leaf as measured by EPID was found. The size of this effect is on the 
order of 25% of the neighbouring leaf's offset. 
Conclusions: The leaf positioning stability of the Elekta Agility is 
within 0.2mm, over a 3 month period half a year after installation. 
The MLCSoftEPID software is a useful alternative to current methods 
of leaf positioning QA used in our institute.  
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Purpose/Objective: Due to the complexity of volumetric modulated 
arc therapy (VMAT), new verification techniques are required. Some 
new systems allow calculation of DVHs from the measured dose 
distribution. In this feasibility study we compare this feature in the 
commercially available 3DVH option of ArcCheck (SunNuclear) with 
the EPID based 3D dosimetry approach that was developed by the NKI-
AVL in Amsterdam and that is being tested in our hospital. 
Materials and Methods: For two different clinical VMAT cases 
(prostate & oesophagus) planned with MONACO (Elekta) we measured 
the clinical treatment plans on a cylindrical phantom with ArcCheck 
and a rectangular phantom with EPID dosimetry at a Synergy (Elekta) 
linac. ArcCheck translates deviations measured by the diodes at the 
outer boundary of the phantom to deviations in the delivered patient 
dose.The EPID dosimetry uses a back projection algorithm to convert 
doses measured at the EPID to 3D doses inside the patient or 
phantom. To study the sensitivity of both methods, two types of 
delivery errors have been introduced in the delivered treatment 
plans. Systematic errors in the leaf position calibration of 0.5, 1, 1.5, 
and 2mm (open or close) and fixing leaf positions during treatment (of 
1 or 2 leaves). We have compared the gamma-statistics (3%/3mm) and 
the measured and planned DVHs. 
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Results: In Fig. 1 DVHs of PTV and two OARs are shown for Monaco, 
3DVH, and EPID dosimetry for the two cases without introduced 
errors. The prostate case shows reasonable resemblance for all 
volumes, although the measured PTV dose spread is larger than 
planned and doses are somewhat higher for the EPID dosimetry. The 
latter is probably due to the phantom shape being smaller than the 
patient, yielding higher doses. This is a disadvantage of direct DVH 
measurements in phantoms. Likewise, the oesophagus case shows 
lower EPID dosimetry values. To reduce the effect of shape 
differences, we show the relative dose difference as a result of the 
introduced errors (with respect to the original DVHs of Fig. 1) in Table 
1. It is clear that both systems can distinguish larger from smaller 
errors, but although the mean difference between the relative Dmean 
changes is small (0.4%), the standard deviation is still considerable 
(3.6%). Further investigations are required to validate DVH 
measurements of both systems. 
 
 
Conclusions: Current dosimetry techniques can measure DVHs of 
VMAT plans but clinical implementation requires further verification 
of the results shown by these systems. We are developing more 
extensive tests for this purpose.  
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Purpose/Objective: The aim of radiation theragnostics is to integrate 
functional and molecular imaging data into radiation treatment 
planning to generate a heterogeneous dose prescription that takes 
into account 3D-profiles of a specific biological parameter (e.g. FDG 
tumour uptake, hypoxia, drug uptake). It is of crucial importance to 
develop preclinical models to identify the best scenarios to be further 
tested in clinical trials. Our group is investigating the validity of 
molecular imaging-based 'radiation dose painting' in a rat rhabdomyo-
sarcoma model. The size of biological targeted volumes (BTVs) 
obtained by PET-based segmentation entails the irradiation of small 
fields (<2 cm3). The aim of the present study was to test the accuracy 
of two calculation algorithms for small field doses, both in the case of 
static beams and arc treatment, such as with Rapid Arc.  
Materials and Methods: Dose calculations were performed using 
Eclipse version 10.0 (Varian Medical Systems, Palo Alto) with the 
anisotropic analytical algorithm (AAA) and the Acuros XB algorithm. 
The beam models for both algorithms were generated from data 
collected for a 6 MV beam of a Varian Truebeam linear accelerator 
with a 120 leaf Millennium MLC using acc13 ion chamber (PTW) and a 
diamond detector (PTW). We investigated dose accuracy for square 
fields (between 0.5x0.5 cm2 and 4x4 cm2) and several rectangular 
fields (between 0.5x0.8 cm2 and 2x3 cm2) irradiated with a static 
beam. Acuros XB and AAA were configured for stereotactic use,and 
dose calculations were performed with a grid size set at 1 mm. The 
impact of different focal spot sizes on dose calculations was also 
assessed. Comparing measurements of output factors(OFs) and 
percentage depth dose values (PDDs) were performed with 
Gafchromic EBT2 films (ISP) in water equivalent phantoms. Film dose 
analysis and comparison with Eclipse output dose distributions were 
performed using a triple-channel dosimetry method. 
Results: The dose algorithms predicted OFs within 1% of the values 
measured by detector and film measurements. However, for fields 
below 1x1 cm2, for which no calibration data can be included in the 
beam model, the discrepancy with film measurements was highly 
dependent on the focal spot size. Differences between Eclipse 
prediction and film measurements were between 3% and 10% for field 
sizes of 0.8 x 0.8 cm2 and 0.5x0.5 cm2, respectively.  
Conclusions: Our preliminary results show that for commissioning of 
MV photon beams for small fields, EBT2 film dosimetry might allow to 
better quantify accuracy of dose calculations compared to diode and 
diamond detector dosimetry. We are currently testing accuracy of 
dose calculations by EBT2 film dosimetry, using appropriate 
phantoms, also for heterogeneous treatment plans prepared on our 
preclinical tumour model. Altogether, our work will prove the 
feasibility and provide the methodology to test radiation 'dose 
painting' preclinically using state-of-the-art clinical platforms.  
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Purpose/Objective: Patient-specific quality assurance is necessary to 
evaluate the deliverability and accuracy of advanced radiation 
therapy deliveries, however the ability of different detector types to 
flag treatment plans as problematic is poorly understood. 
Materials and Methods: Five VMAT treatment plans were developed 
using the Eclipse v 8.8 treatment planning system (Varian Medical 
Systems, Palo Alto, CA, USA). The treatment plans were then 
imported into a custom in-house software program that was designed 
to systematically modify both banks of the MLC leaf positions by ±0.5, 
±1 and ±2 mm (Note +=MLC open, -=MLC close). The modified 
treatment plans were then simulated with errors introduced and then 
delivered to radiochromic film, EPID and the ArcCheck device 
(SunNuclear Corporation, Melbourne, FL, USA). The simulated plans 
for the EPID were modified such that all control points occurred at 
gantry=0°. The plans were evaluated as simulations in Eclipse and 
then delivered to the detectors. Analysis was done with gamma 
analysis (Dd=2%,DTA=2mm) using the un-modified plan as the 
reference.  
Results: For the Eclipse simulations, ArcCheck produced the largest 
average gamma value change for all magnitudes of MLC positional 
errors. Linear regression of gamma change per mm MLC gap change 
yielded slopes of 0.31 Δgamma/mm for ArcCheck, 0.26 Δgamma/mm 
for EPID and 0.22 Δgamma/mm for radiochromic film.Eclipse 
simulation agreed with experimental measurement within <5% for 
ArcCheck and EPID but not for film. 
Conclusions: Sensitivity analysis of three different detectors were 
analysed for 5 VMAT prostate cases and yielded ArcCheck as the most 
sensitive detector followed by EPID and then film. Future components 
to this study will investigate smaller magnitudes of error (i.e ±0.1 and 
0.25 mm) and will analyse γ(2%,2mm) pass rates for these detectors 
to understand each detectors sensitivity for catching MLC open/close 
positional errors.  
   
 
 
 
 
